CLB FY 2014 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2014 Earnings

Reported February 17, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$1.1B	—	$1.1B	—	1.1%
Op. Income	$347M	—	$333M	—	3.9%
Gross Margin	36.2%	—	35.9%	—	0.4pp
Net Margin	23.7%	—	22.6%	—	1.1pp
EPS (Diluted)	$5.77	—	$5.28	—	9.3%
Free Cash Flow	$266M	—	$259M	—	2.6%

Revenue Flow

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$692M
GROSS PROFIT	$393M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$46M
SG&A Expenses	$46M
Other Expenses	$0
Operating Expenses	$46M
Cost & Expenses	$738M
OPERATING INCOME	$347M
Interest Income	$403.0K
Interest Expense	$11M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$336M
Income Tax Expense	$77M
Net Income from Continuing Ops	$259M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$257M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$257M
D&A	$27M
EBIT	$347M
EBITDA	$373M
EPS	$6
EPS Diluted	$6

Income Statement

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$692M
GROSS PROFIT	$393M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$46M
SG&A Expenses	$46M
Other Expenses	$0
Operating Expenses	$46M
Cost & Expenses	$738M
OPERATING INCOME	$347M
Interest Income	$403.0K
Interest Expense	$11M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$336M
Income Tax Expense	$77M
Net Income from Continuing Ops	$259M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$257M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$257M
D&A	$27M
EBIT	$347M
EBITDA	$373M
EPS	$6
EPS Diluted	$6

Cash Flow Statement

Item	Amount
Net Income	$259M
Depreciation & Amortization	$27M
Stock-Based Compensation	$20M
Deferred Income Tax	$5M
Other Non-Cash Items	-$359.0K
Change in Working Capital	-$7M
OPERATING CASH FLOW	$303M
Capital Expenditure	-$37M
Acquisitions (Net)	-$1M
Purchases of Investments	-$4M
Sales/Maturities of Investments	$0
Other Investing Activities	-$37M
NET CASH FROM INVESTING	-$42M
Net Debt Issuance	$89M
Common Stock Repurchased	-$264M
Common Dividends Paid	-$89M
Other Financing Activities	$1M
NET CASH FROM FINANCING	-$263M
FREE CASH FLOW	$266M
Net Change in Cash	-$2M

Balance Sheet

Item	Amount
Cash & Equivalents	$23M
Short-Term Investments	$0
Net Receivables	$197M
Inventory	$43M
Other Current Assets	$24M
TOTAL CURRENT ASSETS	$302M
PP&E (Net)	$149M
Goodwill	$164M
Intangible Assets	$11M
Long-Term Investments	$2M
Tax Assets	$4M
Other Non-Current Assets	-$6M
TOTAL NON-CURRENT ASSETS	$374M
TOTAL ASSETS	$676M
Account Payables	$47M
Short-Term Debt	$0
Deferred Revenue	$11M
Other Current Liabilities	$31M
TOTAL CURRENT LIABILITIES	$132M
Long-Term Debt	$354M
Deferred Revenue NC	-$7M
Deferred Tax Liabilities	$7M
Other Non-Current Liabilities	$89M
TOTAL NON-CURRENT LIABILITIES	$450M
TOTAL LIABILITIES	$582M
Common Stock	$1M
Additional Paid-In Capital	$0
Retained Earnings	$416M
Treasury Stock	-$318M
Accum. Other Comp. Income	-$12M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$94M
Minority Interest	$6M
TOTAL EQUITY	$100M
TOTAL LIABILITIES & EQUITY	$676M
Total Debt	$356M
Net Debt	$333M